Global Perspective on Kidney Transplantation in Malaysia
[No abstract available]
Published in: | Kidney360 |
---|---|
Main Author: | Abdul Hafidz M.I.; Haron H.; Abdul Wahab M.Z. |
Format: | Article |
Language: | English |
Published: |
Lippincott Williams and Wilkins
2024
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198910390&doi=10.34067%2fKID.0000000000000510&partnerID=40&md5=73e9578fe70a6c9393cc7efdaa872d4c |
Similar Items
-
Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients
by: Hamzah S.; Teh L.K.; Siew J.S.K.; Ahmad G.; Wong H.S.; Zakaria Z.A.; Salleh M.Z.
Published: (2014) -
Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: A global survey by the International Society of Nephrology
by: Wijewickrama E.S.; Abdul Hafidz M.I.; Robinson B.M.; Johnson D.W.; Liew A.; Dreyer G.; Caskey F.J.; Bello A.K.; Zaidi D.; Damster S.; Salaro S.; Luyckx V.A.; Bajpai D.
Published: (2022) -
Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
by: Francis, et al.
Published: (2024) -
Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
by: Francis A.; Wainstein M.; Irish G.; Abdul Hafidz M.I.; Chen T.; Cho Y.; Htay H.; Kanjanabuch T.; Lalji R.; Neuen B.L.; See E.; Shah A.; Smyth B.; Tungsanga S.; Viecelli A.; Yeung E.K.; Arruebo S.; Bello A.K.; Caskey F.J.; Damster S.; Donner J.-A.; Jha V.; Johnson D.W.; Levin A.; Malik C.; Nangaku M.; Okpechi I.G.; Tonelli M.; Ye F.; Wong M.G.; Bavanandan S.; Abdul Gafor A.H.; Amouzegar A.; Bennett P.; Chicano S.L.; Davids M.R.; Davison S.N.; Diongole H.M.; Divyaveer S.; Ekrikpo U.E.; Ethier I.; Fong V.K.; Fung W.W.-S.; Ghimire A.; Gopal B.; Phan H.A.H.; Harris D.C.H.; Houston G.; Ibrahim K.S.; Jardine M.J.; Jindal K.; Kantachuvesiri S.; Kelly D.M.; Kerr P.; Kim S.; Krishnasamy R.; Kwek J.L.; Lee V.; Liew A.; Lim C.Y.; Lydia A.; Nalado A.M.; Olanrewaju T.O.; Osman M.A.; Petrova A.; Pyar K.P.; Riaz P.; Saad S.; Sakajiki A.M.; Sengthavisouk N.; Sozio S.M.; Srisawat N.; Tan E.; Tiv S.; Tomacruz Amante I.D.; Villanueva A.R.; Walker R.; Walker R.; Zaidi D.
Published: (2024) -
Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|
by: Francis A.; Abdul Hafidz M.I.; Ekrikpo U.E.; Chen T.; Wijewickrama E.; Tannor E.K.; Nakhoul G.; Wong M.M.Y.; Pereira-Kamath N.; Chanchlani R.; Kalyesubula R.; Karam S.; Kumar V.; Calice-Silva V.; Jha V.
Published: (2022)